Norwalk virus infection of volunteers: new insights based on improved assays.

PubWeight™: 4.37‹?› | Rank: Top 1%

🔗 View Article (PMID 8014518)

Published in J Infect Dis on July 01, 1994

Authors

D Y Graham1, X Jiang, T Tanaka, A R Opekun, H P Madore, M K Estes

Author Affiliations

1: Div. of Molecular Virology, Baylor College of Medicine, Houston, TX 77030.

Articles citing this

Norovirus gastroenteritis. N Engl J Med (2009) 7.66

Murine norovirus: a model system to study norovirus biology and pathogenesis. J Virol (2006) 3.91

Norovirus vaccine against experimental human Norwalk Virus illness. N Engl J Med (2011) 3.78

Norwalk virus shedding after experimental human infection. Emerg Infect Dis (2008) 3.70

Diagnosis of noncultivatable gastroenteritis viruses, the human caliciviruses. Clin Microbiol Rev (2001) 3.28

Norwalk virus-like particle hemagglutination by binding to h histo-blood group antigens. J Virol (2003) 3.15

Sequence diversity of small, round-structured viruses in the Norwalk virus group. J Virol (1994) 3.11

Pathogenesis of a genogroup II human norovirus in gnotobiotic pigs. J Virol (2006) 3.02

Norwalk virus open reading frame 3 encodes a minor structural protein. J Virol (2000) 2.96

Murine noroviruses comprising a single genogroup exhibit biological diversity despite limited sequence divergence. J Virol (2007) 2.84

Detection of Norwalk virus and hepatitis A virus in shellfish tissues with the PCR. Appl Environ Microbiol (1995) 2.73

Murine norovirus 1 infection is associated with histopathological changes in immunocompetent hosts, but clinical disease is prevented by STAT1-dependent interferon responses. J Virol (2007) 2.68

Adjuvanted intranasal Norwalk virus-like particle vaccine elicits antibodies and antibody-secreting cells that express homing receptors for mucosal and peripheral lymphoid tissues. J Infect Dis (2010) 2.64

Cellular and humoral immunity following Snow Mountain virus challenge. J Virol (2005) 2.59

Attachment and entry of recombinant Norwalk virus capsids to cultured human and animal cell lines. J Virol (1996) 2.51

Determination of the 50% human infectious dose for Norwalk virus. J Infect Dis (2013) 2.50

Expression, self-assembly, and antigenicity of a snow mountain agent-like calicivirus capsid protein. J Clin Microbiol (1995) 2.43

Development of a microsphere-based serologic multiplexed fluorescent immunoassay and a reverse transcriptase PCR assay to detect murine norovirus 1 infection in mice. Clin Diagn Lab Immunol (2005) 2.25

Serological correlate of protection against norovirus-induced gastroenteritis. J Infect Dis (2010) 2.21

Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice. Proc Natl Acad Sci U S A (1996) 2.00

Oral immunization with recombinant Norwalk virus-like particles induces a systemic and mucosal immune response in mice. J Virol (1998) 1.80

Use of heat release and an internal RNA standard control in reverse transcription-PCR detection of Norwalk virus from stool samples. J Clin Microbiol (1997) 1.77

Noroviruses: The leading cause of gastroenteritis worldwide. Discov Med (2010) 1.73

Specific proteolytic cleavage of recombinant Norwalk virus capsid protein. J Virol (1995) 1.69

Immune mechanisms responsible for vaccination against and clearance of mucosal and lymphatic norovirus infection. PLoS Pathog (2008) 1.69

Antibody is critical for the clearance of murine norovirus infection. J Virol (2008) 1.69

MDA-5 recognition of a murine norovirus. PLoS Pathog (2008) 1.68

Pathogenesis of noroviruses, emerging RNA viruses. Viruses (2010) 1.67

Comparative pathogenesis of tissue culture-adapted and wild-type Cowden porcine enteric calicivirus (PEC) in gnotobiotic pigs and induction of diarrhea by intravenous inoculation of wild-type PEC. J Virol (2001) 1.66

Norwalk virus-specific binding to oyster digestive tissues. Emerg Infect Dis (2006) 1.63

Recombinant Norwalk virus-like particles administered intranasally to mice induce systemic and mucosal (fecal and vaginal) immune responses. J Virol (2001) 1.59

Herd immunity to GII.4 noroviruses is supported by outbreak patient sera. J Virol (2009) 1.51

Asymptomatic and symptomatic excretion of noroviruses during a hospital outbreak of gastroenteritis. J Clin Microbiol (2004) 1.48

Genetic and phenotypic characterization of GII-4 noroviruses that circulated during 1987 to 2008. J Virol (2010) 1.46

C-terminal arginine cluster is essential for receptor binding of norovirus capsid protein. J Virol (2006) 1.45

Cross-reactivity among several recombinant calicivirus virus-like particles (VLPs) with monoclonal antibodies obtained from mice immunized orally with one type of VLP. J Clin Microbiol (2002) 1.40

Identification of an epitope common to genogroup 1 "norwalk-like viruses". J Clin Microbiol (2000) 1.40

Noroviruses - State of the Art. Food Environ Virol (2010) 1.39

Duration of immunity to norovirus gastroenteritis. Emerg Infect Dis (2013) 1.38

Protruding domain of capsid protein is necessary and sufficient to determine murine norovirus replication and pathogenesis in vivo. J Virol (2012) 1.34

Detection of immunoglobulin M (IgM), IgA, and IgG Norwalk virus-specific antibodies by indirect enzyme-linked immunosorbent assay with baculovirus-expressed Norwalk virus capsid antigen in adult volunteers challenged with Norwalk virus. J Clin Microbiol (1994) 1.33

Cytokine and antibody responses in gnotobiotic pigs after infection with human norovirus genogroup II.4 (HS66 strain). J Virol (2007) 1.31

Norovirus excretion in an aged-care setting. J Clin Microbiol (2008) 1.27

Norovirus infectivity in humans and persistence in water. Appl Environ Microbiol (2011) 1.26

Genogroup I and II noroviruses detected in stool samples by real-time reverse transcription-PCR using highly degenerate universal primers. Appl Environ Microbiol (2004) 1.21

Structural basis for broad detection of genogroup II noroviruses by a monoclonal antibody that binds to a site occluded in the viral particle. J Virol (2012) 1.21

Serological responses to experimental Norwalk virus infection measured using a quantitative duplex time-resolved fluorescence immunoassay. Clin Vaccine Immunol (2011) 1.20

A single-amino-acid substitution in the P2 domain of VP1 of murine norovirus is sufficient for escape from antibody neutralization. J Virol (2007) 1.20

Enhanced hygiene measures and norovirus transmission during an outbreak. Emerg Infect Dis (2009) 1.17

Development of methods to detect "Norwalk-like viruses" (NLVs) and hepatitis A virus in delicatessen foods: application to a food-borne NLV outbreak. Appl Environ Microbiol (2000) 1.15

Porcine enteric caliciviruses: genetic and antigenic relatedness to human caliciviruses, diagnosis and epidemiology. Vaccine (2006) 1.14

Asymptomatic norovirus infection in Mexican children. J Clin Microbiol (2006) 1.13

Human and animal enteric caliciviruses in oysters from different coastal regions of the United States. Appl Environ Microbiol (2006) 1.11

Critical review of norovirus surrogates in food safety research: rationale for considering volunteer studies. Food Environ Virol (2011) 1.10

Use of solid-phase immune electron microscopy for classification of Norwalk-like viruses into six antigenic groups from 10 outbreaks of gastroenteritis in the United States. J Clin Microbiol (1995) 1.09

Critical role for interferon regulatory factor 3 (IRF-3) and IRF-7 in type I interferon-mediated control of murine norovirus replication. J Virol (2012) 1.09

Collaborative evaluation of a method for the detection of Norwalk virus in shellfish tissues by PCR. Appl Environ Microbiol (1996) 1.04

Molecular identification and genetic analysis of Norovirus genogroups I and II in water environments: comparative analysis of different reverse transcription-PCR assays. Appl Environ Microbiol (2007) 1.02

Molecular cloning, expression, and antigenicity of Seto virus belonging to genogroup I Norwalk-like viruses. J Clin Microbiol (2000) 1.01

Foodborne norovirus outbreak: the role of an asymptomatic food handler. BMC Infect Dis (2010) 1.01

Serological Correlates of Protection against a GII.4 Norovirus. Clin Vaccine Immunol (2015) 1.01

Prevalence of human calicivirus infections in Kenya as determined by enzyme immunoassays for three genogroups of the virus. J Clin Microbiol (1998) 1.01

Clinical characteristics of viral intestinal infection in preterm and term neonates. Eur J Clin Microbiol Infect Dis (2010) 1.00

Monoclonal antibodies for detection of Norwalk virus antigen in stools. J Clin Microbiol (1995) 0.99

Development of Norwalk virus-specific monoclonal antibodies with therapeutic potential for the treatment of Norwalk virus gastroenteritis. J Virol (2013) 0.99

Economic value of norovirus outbreak control measures in healthcare settings. Clin Microbiol Infect (2010) 0.98

Detection of Norwalk virus and other genogroup 1 human caliciviruses by a monoclonal antibody, recombinant-antigen-based immunoglobulin M capture enzyme immunoassay. J Clin Microbiol (1998) 0.98

Gastroenteritis outbreaks associated with Norwalk-like viruses and their investigation by nested RT-PCR. BMC Microbiol (2001) 0.98

Development of a reverse transcription-PCR-DNA enzyme immunoassay for detection of "Norwalk-like" viruses and hepatitis A virus in stool and shellfish. Appl Environ Microbiol (2001) 0.97

Studies of epidemiology and seroprevalence of bovine noroviruses in Germany. J Clin Microbiol (2003) 0.97

Antibody responses to norovirus genogroup GI.1 and GII.4 proteases in volunteers administered Norwalk virus. Clin Vaccine Immunol (2012) 0.97

Detection of enteric viruses in shellfish from the Norwegian coast. Appl Environ Microbiol (2004) 0.95

Self-assembly of the recombinant capsid protein of a bovine norovirus (BoNV) into virus-like particles and evaluation of cross-reactivity of BoNV with human noroviruses. J Clin Microbiol (2005) 0.95

Viral gastroenteritis: small round structured viruses, caliciviruses and astroviruses. Part II. The epidemiological perspective. J Clin Pathol (1996) 0.94

The dynamics of norovirus outbreak epidemics: recent insights. Int J Environ Res Public Health (2011) 0.92

Diagnosis of norwalk virus infection by indirect enzyme immunoassay detection of salivary antibodies to recombinant norwalk virus antigen. Clin Diagn Lab Immunol (2004) 0.91

Economic impact of outbreaks of norovirus infection in hospitals. Infect Control Hosp Epidemiol (2011) 0.91

An epidemiological investigation of Norwalk virus infection in South Africa. Epidemiol Infect (1996) 0.90

Fast detection of Noroviruses using a real-time PCR assay and automated sample preparation. BMC Infect Dis (2004) 0.89

Noninfectious virus-like particle antigen for detection of swine vesicular disease virus antibodies in pigs by enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol (2005) 0.88

Effect of food residues on norovirus survival on stainless steel surfaces. PLoS One (2011) 0.87

Norovirus infections in asymptomatic food handlers in elementary schools without norovirus outbreaks in some regions of Incheon, Korea. J Korean Med Sci (2011) 0.87

A non-foodborne norovirus outbreak among school children during a skiing holiday, Austria, 2007. Wien Klin Wochenschr (2009) 0.85

Norovirus immunology: Of mice and mechanisms. Eur J Immunol (2015) 0.85

Multiple viral infections and genomic divergence among noroviruses during an outbreak of acute gastroenteritis. J Clin Microbiol (2006) 0.84

Immunoglobulin M antibody test to detect genogroup II Norwalk-like virus infection. J Clin Microbiol (1999) 0.83

A serosurvey of water-borne pathogens amongst canoeists in South Africa. Epidemiol Infect (1995) 0.82

Norovirus infection as a cause of sporadic healthcare-associated diarrhoea. J Hosp Infect (2009) 0.81

Noroviruses as a Cause of Diarrhea in Immunocompromised Pediatric Hematopoietic Stem Cell and Solid Organ Transplant Recipients. Am J Transplant (2015) 0.81

Evidence-Based interventions of Norovirus outbreaks in China. BMC Public Health (2016) 0.78

Application of salivary antibody immunoassays for the detection of incident infections with Norwalk virus in a group of volunteers. J Immunol Methods (2015) 0.76

Outbreak of acute gastroenteritis among emergency department staff. Emerg Med J (2007) 0.76

Inhibition of Tulane virus replication in vitro with RNA interference. J Med Virol (2013) 0.76

The spread and control of norovirus outbreaks among hospitals in a region: a simulation model. Open Forum Infect Dis (2014) 0.76

An examination of co-infection in acute gastroenteritis and histo-blood group antigens leading to viral infection susceptibility. Biomed Rep (2016) 0.75

The Norovirus NS3 protein is a dynamic lipid- and microtubule-associated protein involved in viral RNA replication. J Virol (2016) 0.75

Occurrence of novel GII.17 and GII.21 norovirus variants in the coastal environment of South Korea in 2015. PLoS One (2017) 0.75

The role of hand hygiene in controlling norovirus spread in nursing homes. BMC Infect Dis (2016) 0.75

Articles by these authors

The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature (1997) 33.47

Essential Bacillus subtilis genes. Proc Natl Acad Sci U S A (2003) 14.01

Construction of a colicin E1-R factor composite plasmid in vitro: means for amplification of deoxyribonucleic acid. J Bacteriol (1975) 13.95

Soft lithography in biology and biochemistry. Annu Rev Biomed Eng (2001) 11.36

Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J Virol (1992) 8.35

Fate of the mammalian cranial neural crest during tooth and mandibular morphogenesis. Development (2000) 8.07

Complete genome sequence of an aerobic hyper-thermophilic crenarchaeon, Aeropyrum pernix K1. DNA Res (1999) 7.39

Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc Natl Acad Sci U S A (1997) 7.08

The nucleotide sequence of pUB110: some salient features in relation to replication and its regulation. Plasmid (1986) 7.07

Rotavirus gene structure and function. Microbiol Rev (1989) 6.95

Ordered recruitment of transcription and chromatin remodeling factors to a cell cycle- and developmentally regulated promoter. Cell (1999) 6.83

Complete sequence and gene organization of the genome of a hyper-thermophilic archaebacterium, Pyrococcus horikoshii OT3. DNA Res (1998) 6.79

X-ray crystallographic structure of the Norwalk virus capsid. Science (1999) 6.58

Essential role of Stat6 in IL-4 signalling. Nature (1996) 6.56

Sequence and genomic organization of Norwalk virus. Virology (1993) 6.25

The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity (1994) 6.18

Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group. N Engl J Med (1996) 6.01

Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol (1992) 5.93

Norwalk virus genome cloning and characterization. Science (1990) 5.83

p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell (2000) 5.64

Cohesin's binding to chromosomes depends on a separate complex consisting of Scc2 and Scc4 proteins. Mol Cell (2000) 5.49

The 5'-terminal sequence of the hepatitis C virus genome. Jpn J Exp Med (1990) 5.46

Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus. J Virol (1993) 5.41

Rotaviruses: a review. Curr Top Microbiol Immunol (1983) 5.24

Generation of destabilized green fluorescent protein as a transcription reporter. J Biol Chem (1998) 5.22

Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: comparative study of four distinct genotypes. Virology (1992) 5.16

Campylobacter pylori detected noninvasively by the 13C-urea breath test. Lancet (1987) 5.02

Proteolytic enhancement of rotavirus infectivity: molecular mechanisms. J Virol (1981) 4.87

Structural polypeptides of simian virus 40. J Virol (1971) 4.83

Syringe method for stepwise chemical synthesis of oligonucleotides. Nucleic Acids Res (1982) 4.70

Direct stimulation of the guanine nucleotide exchange activity of p115 RhoGEF by Galpha13. Science (1998) 4.62

In vitro transcription and translation of simian rotavirus SA11 gene products. J Virol (1980) 4.40

p115 RhoGEF, a GTPase activating protein for Galpha12 and Galpha13. Science (1998) 4.32

Age-dependent diarrhea induced by a rotaviral nonstructural glycoprotein. Science (1996) 4.08

A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection. N Engl J Med (1982) 4.04

Identification and characterization of the potential promoter regions of 1031 kinds of human genes. Genome Res (2001) 4.03

Taxonomy of the caliciviruses. J Infect Dis (2000) 3.94

A novel signaling molecule, p130, forms stable complexes in vivo with v-Crk and v-Src in a tyrosine phosphorylation-dependent manner. EMBO J (1994) 3.88

A neomycin resistance gene cassette selectable in a single copy state in the Bacillus subtilis chromosome. Nucleic Acids Res (1989) 3.87

Real-time detection system for quantification of hepatitis C virus genome. Gastroenterology (1999) 3.83

Detection of Norwalk virus in stool by polymerase chain reaction. J Clin Microbiol (1992) 3.82

Transcriptional sequencing: A method for DNA sequencing using RNA polymerase. Proc Natl Acad Sci U S A (1998) 3.78

High guanine plus cytosine content in the third letter of codons of an extreme thermophile. DNA sequence of the isopropylmalate dehydrogenase of Thermus thermophilus. J Biol Chem (1984) 3.76

An endothelial receptor for oxidized low-density lipoprotein. Nature (1997) 3.76

Calcium-induced conformational transition revealed by the solution structure of apo calmodulin. Nat Struct Biol (1995) 3.75

The M1- and M2-type isozymes of rat pyruvate kinase are produced from the same gene by alternative RNA splicing. J Biol Chem (1986) 3.64

Rotavirus infections in infants as protection against subsequent infections. N Engl J Med (1996) 3.61

LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sites. J Mol Graph Model (2003) 3.60

IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production. J Immunol (1998) 3.56

Diverse transcriptional initiation revealed by fine, large-scale mapping of mRNA start sites. EMBO Rep (2001) 3.47

Molecular mechanics of calcium-myristoyl switches. Nature (1997) 3.36

Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia. Blood (1999) 3.33

Sequence analysis of hepatitis C virus isolated from a fulminant hepatitis patient. J Med Virol (2001) 3.29

Diagnosis of noncultivatable gastroenteritis viruses, the human caliciviruses. Clin Microbiol Rev (2001) 3.28

Specific enzyme-linked immunoassay for rotavirus serotypes 1 and 3. J Clin Microbiol (1985) 3.23

Genetic drift of hepatitis C virus during an 8.2-year infection in a chimpanzee: variability and stability. Virology (1992) 3.22

Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitors. Proc Natl Acad Sci U S A (2005) 3.20

A high-throughput SNP typing system for genome-wide association studies. J Hum Genet (2001) 3.18

Sequence diversity of small, round-structured viruses in the Norwalk virus group. J Virol (1994) 3.11

Water source as risk factor for Helicobacter pylori infection in Peruvian children. Gastrointestinal Physiology Working Group. Lancet (1991) 3.09

Size and shape effects in the biodistribution of intravascularly injected particles. J Control Release (2009) 3.08

Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT. Nat Genet (1996) 3.07

Altered pain perception and inflammatory response in mice lacking prostacyclin receptor. Nature (1997) 3.07

N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide, a calmodulin antagonist, inhibits cell proliferation. Proc Natl Acad Sci U S A (1981) 3.04

Complete genome sequence of an aerobic thermoacidophilic crenarchaeon, Sulfolobus tokodaii strain7. DNA Res (2001) 2.99

Norwalk virus open reading frame 3 encodes a minor structural protein. J Virol (2000) 2.96

Ultrastructural localization of rotavirus antigens using colloidal gold. Virus Res (1984) 2.95

Cloning of the genes for penicillinase, penP and penI, of Bacillus licheniformis in some vector plasmids and their expression in Escherichia coli, Bacillus subtilis, and Bacillus licheniformis. J Bacteriol (1981) 2.93

Single-molecule analysis of chemotactic signaling in Dictyostelium cells. Science (2001) 2.89

Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3. Nature (1998) 2.88

Familial gastrointestinal stromal tumours with germline mutation of the KIT gene. Nat Genet (1998) 2.80

Nature of phosphorus limitation in the ultraoligotrophic eastern Mediterranean. Science (2005) 2.79

Localization of VP4 neutralization sites in rotavirus by three-dimensional cryo-electron microscopy. Nature (1990) 2.77

Detection of Norwalk virus and hepatitis A virus in shellfish tissues with the PCR. Appl Environ Microbiol (1995) 2.73

Finer features for functional microdevices. Nature (2001) 2.73

Solution structure of the homodimeric core domain of Escherichia coli histidine kinase EnvZ. Nat Struct Biol (1999) 2.72

Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5'-noncoding region. Jpn J Exp Med (1990) 2.72

Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Proc Natl Acad Sci U S A (1996) 2.70

Correlation of patient immune responses with genetically characterized small round-structured viruses involved in outbreaks of nonbacterial acute gastroenteritis in the United States, 1990 to 1995. J Med Virol (1997) 2.70

Detection of enteric viruses in oysters by using the polymerase chain reaction. Appl Environ Microbiol (1993) 2.69

Identification, synthesis, and modifications of simian rotavirus SA11 polypeptides in infected cells. J Virol (1982) 2.67

A plaque assay for the simian rotavirus SAII. J Gen Virol (1979) 2.65

Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver. Nat Genet (1995) 2.65

Solid phase synthesis of oligoribonucleotides using o-nitrobenzyl protection of 2'-hydroxyl via a phosphite triester approach. Nucleic Acids Res (1986) 2.64

Multinuclearity and increased ploidy caused by overexpression of the aurora- and Ipl1-like midbody-associated protein mitotic kinase in human cancer cells. Cancer Res (1998) 2.63

Three-dimensional visualization of mRNA release from actively transcribing rotavirus particles. Nat Struct Biol (1997) 2.63

Isolation and characterization of four plasmids from Bacillus subtilis. J Bacteriol (1977) 2.59

Comparison of the reactivities of baculovirus-expressed recombinant Norwalk virus capsid antigen with those of the native Norwalk virus antigen in serologic assays and some epidemiologic observations. J Clin Microbiol (1993) 2.58

Interactions of the LIM-domain-binding factor Ldb1 with LIM homeodomain proteins. Nature (1996) 2.57

Comparative study on the antibacterial activity of phytochemical flavanones against methicillin-resistant Staphylococcus aureus. J Ethnopharmacol (1996) 2.57

Recombinant Norwalk virus-like particles given orally to volunteers: phase I study. Gastroenterology (1999) 2.54

Attachment and entry of recombinant Norwalk virus capsids to cultured human and animal cell lines. J Virol (1996) 2.51

Rotavirus stability and inactivation. J Gen Virol (1979) 2.48

Characterization of virus-like particles produced by the expression of rotavirus capsid proteins in insect cells. J Virol (1994) 2.48

p53DINP1, a p53-inducible gene, regulates p53-dependent apoptosis. Mol Cell (2001) 2.47

Three-dimensional structure of baculovirus-expressed Norwalk virus capsids. J Virol (1994) 2.46